The field of lupus research continues to advance, bringing forward innovative approaches aimed at improving outcomes for people living with the disease. In this recording from our recent virtual webinar, discover an exciting new area of lupus research focused on T-cell engagers — a potential therapy designed to help “reset” the immune system. Expert speakers explain how T-cell engagers work, where these therapies currently stand in clinical trials, what participation may involve, and important considerations around safety and side effects. Whether you are living with lupus, caring for someone who is, or looking to stay informed about emerging treatment options, this session provides clear, patient-friendly insights into a promising area of research.

Speakers:

• Maximilian Ferdinand Konig, MD, Assistant Professor of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine
• Richard Alan Furie, MD,  Professor of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
• John R. P. Tesser, MD, FACP, FACR, MACR, Rheumatologist, Arizona Arthritis and Rheumatology Associates, P.C.

Event Resources:

• Research Accelerated by You (RAY®)
• CAR Cell Therapy Information Center
• Unlocking the Potential of CAR Cell Therapy, T-Cell Engagers, and Beyond

Thank you to our sponsors!